Optomed Oyj
OMXH:OPTOMED
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| FI |
O
|
Optomed Oyj
OMXH:OPTOMED
|
59.8m EUR |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
200.1B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
174.7B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
146.9B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
126B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.4B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.2B EUR |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
52.7B USD |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
49.9B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.2B USD |
Loading...
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
37.9B USD |
Loading...
|
Market Distribution
| Min | -441.9% |
| 30th Percentile | 28.8% |
| Median | 45.6% |
| 70th Percentile | 67.4% |
| Max | 21 276.1% |
Other Profitability Ratios
Optomed Oyj
Glance View
Optomed Oyj engages in the provision of handheld fundus cameras and eye-screening solutions. The company is headquartered in Oulu, Oulun and currently employs 115 full-time employees. The company went IPO on 2019-12-09. The Group's Parent Company, Optomed Oyj, is responsible for, among other things, the management of the Group as well as finance and accounting functions, human resources, legal affairs and corporate communication. The Group's business is managed through two reportable segments: Devices and Software. The Devices segment develops, commercializes and manufactures easy-to-use and affordable handheld fundus cameras. The Software segment develops and sells screening software for diabetic retinopathy and cancer screening for healthcare organizations. The Optomed Group consists of the parent company Optomed Oyj and four subsidiaries in Finland, China, the USA and Hong Kong.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Optomed Oyj is 63.6%, which is below its 3-year median of 65.5%.
Over the last 3 years, Optomed Oyj’s Gross Margin has increased from 62.8% to 63.6%. During this period, it reached a low of 62.8% on Dec 31, 2022 and a high of 68.3% on Sep 30, 2023.
